Learn

Schizophrenia Research Review Issue 46 with Professor Dan Siskind.

This review is a unique Australian publication providing topical, relevant and accessible information for health professionals with an interest in Schizophrenia. In essence, the review is a summary of what we consider to be some of the most significant new studies in this area.

To access this publication please click ‘Enrol Now’ and you’ll be directed to the publication. Then sign up to Research Review at no cost. You can then login with your email and password.

Details

In this issue we feature:

• Challenge: virtual reality-assisted therapy for verbal auditory hallucinations
• Real-world clozapine augmentation with antidepressants
• OPTiMiSE: extrapyramidal symptoms in first-episode schizophrenia
• Paternal age, de novo mutations & schizophrenia onset
• A botulinum neurotoxin clinic for clozapine-induced sialorrhea
• Metacognitive training for psychosis
• Real-world antipsychotic discontinuation & switching
• Retinal age gap, hypertension & diabetes in schizophrenia
• Brief vs. ultra-brief ECT in schizophrenia
• PURPOSE: omega-3 fatty acids in youth at ultra-high risk of psychosis

This activity is accepted by CPD Home as a Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide. 

Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.